Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,621,238
+$136,987 QoQ
Shares Held
18,196
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#1,677
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Csenge Advisory Group holds $34,699,600 across 10 Drug Manufacturers - General names. JNJ ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,327 | $6,389,364 | |
| 2 | ABBV |
AbbVie Inc.
|
25,158 | $6,330,759 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
18,196 | $4,621,238 | |
| 4 | AMGN |
Amgen Inc
|
10,362 | $3,752,287 | |
| 5 | PFE |
Pfizer Inc
|
154,984 | $3,732,014 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
22,416 | $2,832,037 | |
| 7 | NVS |
Novartis AG
|
16,110 | $2,524,759 | |
| 8 | GSK |
GSK plc
|
41,506 | $2,175,744 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,621,238 | 18,196 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,484,251 | 18,345 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $4,369,335 | 21,113 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $4,052,168 | 21,854 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $3,303,677 | 21,628 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,161,242 | 19,062 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,684,147 | 18,560 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $3,539,876 | 21,843 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,343,410 | 22,875 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $3,446,169 | 21,785 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $3,434,486 | 21,912 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,778,650 | 24,261 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $4,863,308 | 29,382 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $4,182,055 | 26,981 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $4,750,471 | 26,892 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $4,428,852 | 27,111 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $4,633,011 | 26,100 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $4,516,706 | 25,485 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,914,327 | 28,727 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,213,535 | 26,090 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $4,732,485 | 28,727 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $3,977,763 | 24,203 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,907,752 | 18,476 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $2,847,032 | 19,123 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,659,735 | 18,913 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,848,015 | 14,093 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||